Laboratory Evaluation at Different Ages

Comprehensive Pediatric Nephrology

Volumn , Issue , 2008, Pages 39-54

  Langlois, Valerie ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882827698     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-04883-5.50008-8     Document Type: Chapter

References (95)

1. Graff SL A handbook of routine urinalysis 1983, Lippincott Williams & Wilkins, Philadelphia. L.A. Biello (Ed.).
2. Brodehl J, Franken A, Gellissen K Maximal tubular reabsorption of glucose in infants and children. Acta Paediatr Scand 1972, 61(4):413-420.
3. Rose B Clinical physiology of acid-base and electrolyte disorders 1994, McGraw-Hill, New York. J.J. Dereck, N. Muza (Eds.).
4. Hogg RJ, et al. National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 2003, 111(6):1416-1421.
5. Kaneko K, et al. Simplified quantification of urinary protein excretion using a novel dipstick in children. Pediatr Nephrol 2005, 20(6):834-836.
6. Ettenger RB The evaluation of the child with proteinuria. Pediatr Ann 1994, 23(9):486-494.
7. Urine protein as diagnostic test: evaluation of proteinuria in children. Nephrology (Carlton) 2004, 9(suppl 3):S15-S19. The CARI guidelines.
8. Mori Y, et al. Urinary creatinine excretion and protein/creatinine ratios vary by body size and gender in children. Pediatr Nephrol 2006, 21(5):683-687.
9. Kim HS, et al. Quantification of proteinuria in children using the urinary protein-osmolality ratio. Pediatr Nephrol 2001, 16(1):73-76.
10. Cole BR, et al. Measurement of renal function without urine collection. A critical evaluation of the constant-infusion technic for determination of inulin and para-aminohippurate. N Engl J Med 1972, 287(22):1109-1114.
11. Florijn KW, et al. Glomerular filtration rate measurement by "single-shot" injection of inulin. Kidney Int 1994, 46(1):252-259.
12. van Rossum LK, et al. Optimal sampling strategies to assess inulin clearance in children by the inulin single-injection method. Clin Chem 2003, 49(7):1170-1179.
13. van Rossum LK, et al. Determination of inulin clearance by single injection or infusion in children. Pediatr Nephrol 2005, 20(6):777-781.
14. Schwartz GJ, Brion LP, Spitzer A The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987, 34(3):571-590.
15. Levey AS Measurement of renal function in chronic renal disease. Kidney Int 1990, 38(1):167-187.
16. Atiyeh BA, Dabbagh SS, B Gruskin AB Evaluation of renal function during childhood. Pediatr Rev 1996, 17(5):175-180.
17. Piepsz A, et al. Guidelines for glomerular filtration rate determination in children. Eur J Nucl Med 2001, 28(3):BP31-BP36.
18. Blaufox MD, et al. Report of the Radionuclides in Nephrourology Committee on renal clearance. J Nucl Med 1996, 37(11):1883-1890.
19. Schwartz GJ, et al. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976, 58(2):259-263.
20. Counahan R, et al. Estimation of glomerular filtration rate from plasma creatinine concentration in children. Arch Dis Child 1976, 51(11):875-878.
21. Mattman A, et al. Estimating pediatric glomerular filtration rates in the era of chronic kidney disease staging. J Am Soc Nephrol 2006, 17(2):487-496.
22. Leger F, et al. Estimation of glomerular filtration rate in children. Pediatr Nephrol 2002, 17(11):903-907.
23. Gaspari F, et al. Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate. J Am Soc Nephrol 1995, 6(2):257-263.
24. Stake G, et al. The clearance of iohexol as a measure of the glomerular filtration rate in children with chronic renal failure. Scand J Clin Lab Invest 1991, 51(8):729-734.
25. Schwartz GJ, et al. Glomerular filtration rate via plasma iohexol disappearance: pilot study for chronic kidney disease in children. Kidney Int 2006, 69(11):2070-2077.
26. Rule AD, et al. Glomerular filtration rate estimated by cystatin C among different clinical presentations. Kidney Int 2006, 69(2):399-405.
27. Finney H, Newman DJ, Price CPP Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Ann Clin Biochem 2000, 37(1):49-59.
28. Knight EL, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004, 65(4):1416-1421.
29. Cimerman N, et al. Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients. Clin Chim Acta 2000, 300(1-2):83-95.
30. Wiesli P, et al. Serum cystatin C is sensitive to small changes in thyroid function. Clin Chim Acta 2003, 338(1-2):87-90.
31. Dharnidharka VR, Kwon C, Stevens G Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002, 40(2):221-226.
32. Larsson A, et al. Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L. Scand J Clin Lab Invest 2004, 64(1):25-30.
33. Grubb A, et al. A cystatin C-based formula without anthropometric variables estimates glomerular filtration rate better than creatinine clearance using the Cockcroft-Gault formula. Scand J Clin Lab Invest 2005, 65(2):153-162.
34. Filler G, Lepage N Should the Schwartz formula for estimation of GFRbe replaced by cystatin C formula?. PediatrNephrol 2003, 18(10):981-985.
35. Sambasivan AS, Lepage N, Filler G Cystatin C intrapatient variability in children with chronic kidney disease is less than serum creatinine. Clin Chem 2005, 51(11):2215-2216.
36. Kruse K, Kracht U, Gopfert G Renal threshold phosphate concentration (TmPO4/GFR). Arch Dis Child 1982, 57(3):217-223.
37. Bijvoet OL Relation of plasma phosphate concentration to renal tubular reabsorption of phosphate. Clin Sci 1969, 37(1):23-36.
38. Walton RJ, Bijvoet OL Nomogram for derivation of renal threshold phosphate concentration. Lancet 1975, 2(7929):309-310.
39. Santer R, et al. The molecular basis of renal glucosuria: mutations in the gene for a renal glucose transporter (SGLT2). J Inherit Metab Dis 2000, 23(suppl 1):178.
40. West ML, et al. Development of a test to evaluate the transtubular potassium concentration gradient in the cortical collecting duct in vivo. Miner Electrolyte Metab 1986, 12(4):226-233.
41. Rodriguez-Soriano J, Ubetagoyena M, Vallo A Transtubular potassium concentration gradient: a useful test to estimate renal aldosterone bio-activity in infants and children. Pediatr Nephrol 1990, 4(2):105-110.
42. Goldstein MB, et al. The urine anion gap: a clinically useful index of ammonium excretion. Am J Med Sci 1986, 292(4):198-202.
43. Batlle DC, et al. The use of the urinary anion gap in the diagnosis of hyperchloremic metabolic acidosis. N Engl J Med 1988, 318(10):594-599.
44. Halperin ML, et al. The urine osmolal gap: a clue to estimate urine ammonium in "hybrid" types of metabolic acidosis. Clin Invest Med 1988, 11(3):198-202.
45. 2 tensions. J Clin Invest 1974, 53(3):669-677.
46. DuBose TD, Caflisch CR Validation of the difference in urine and blood carbon dioxide tension during bicarbonate loading as an index of distal nephron acidification in experimental models of distal renal tubular acidosis. J Clin Invest 1985, 75(4):1116-1123.
47. Kim S, et al. The urine-blood PCO gradient as a diagnostic index of H(+)-ATPase defect distal renal tubular acidosis. Kidney Int 2004, 66(2):761-767.
48. Ghoshal AK, Soldin SJ Evaluation of the Dade Behring Dimension RxL: integrated chemistry system-pediatric reference ranges. Clin Chim Acta 2003, 331(1-2):135-146.
49. Pediatric reference ranges 2003, AACC Press, Washington. ed 4. B.C. Soldin, E.C. Wong (Eds.).
50. Garfinkel HB, Gelfman N Bicarbonate, not 'CO2'. Arch Intern Med 1983, 143(11):2063-2064.
51. Kost GJ, Trent JK, Saeed D Indications for measurement of total carbon dioxide in arterial blood. Clin Chem 1988, 34(8):1650-1652.
52. K/DOQI Clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease. Am J Kidney Dis 2005, 46(4).
53. Biyikli NK, Alpay H, Guran T Hypercalciuria and recurrent urinary tract infections: incidence and symptoms in children over 5 years of age. PediatrNephrol 2005, 20(10):1435-1488.
54. Ghazali S, Barratt TM Urinary excretion of calcium and magnesium in children. Arch Dis Child 1974, 49(2):97-101.
55. Moore E, et al. Idiopathic hypercalciuria in children: prevalence and metabolic characteristics. Journal of Pediatrics 1978, 92(6):906-910.
56. Sorkhi H, Haji Aahmadi M Urinary calcium to creatinin ratio in children. Indian J Pediatr 2005, 72(12):1055-1056.
57. De Santo NG, et al. Population based data on urinary excretion of calcium, magnesium, oxalate, phosphate and uric acid in children from Cimitile (southern Italy). Pediatr Nephrol 1992, 6(2):149-157.
58. So NP, et al. Normal urinary calcium/creatinine ratios in African-American and Caucasian children. Pediatr Nephrol 2001, 16(2):133-139.
59. Vachvanichsanong P, Lebel L, Moore ES Urinary calcium excretion in healthy Thai children. Pediatr Nephrol 2000, 14(8-9):847-850.
60. Butani L, Kalia A Idiopathic hypercalciuria in children-how valid are the existing diagnostic criteria?. Pediatr Nephrol 2004, 19(6):577-582.
61. Richmond W, et al. Random urine calcium/osmolality in the assessment of calciuria in children with decreased muscle mass. Clin Nephrol 2005, 64(4):264-270.
62. Mir S, Serdaroglu E Quantification of hypercalciuria with the urine calcium osmolality ratio in children. Pediatr Nephrol 2005, 20(11):1562-1565.
63. Hilgenfeld MS, et al. Lack of seasonal variations in urinary calcium/creatinine ratio in school-age children. Pediatr Nephrol 2004, 19(10):1153-1155.
64. Polito C, et al. Urinary sodium and potassium excretion in idiopathic hypercalciuria of children. Nephron 2002, 91(1):7-12.
65. Tefekli A, et al. Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference?. Urol Int 2003, 70(4):273-277.
66. Sikora P, et al. Hypocitraturia is one of the major risk factors for nephrocalcinosis in very low birth weight (VLBW) infants. Kidney Int 2003, 63(6):2194-2199.
67. Stapenhorst L, et al. Hypocitraturia as a risk factor for nephrocalcinosis after kidney transplantation. Pediatr Nephrol 2005, 20(5):652-656.
68. Rumsby G Biochemical and genetic diagnosis of the primary hyperoxalurias: a review. Mol Urol 2000, 4(4):349-354.
69. La Manna A, et al. Hyperuricosuria in children: clinical presentation and natural history. Pediatrics 2001, 107(1):86-90.
70. Stapleton FB, Nash DA A screening test for hyperuricosuria. J Pediatr 1983, 102(1):88-90.
71. Dillon MJ, Ryness JM Plasma renin activity and aldosterone concentration in children. Br Med J 1975, 4(5992):316-319.
72. Dillon MJ, Shah V, Barratt TM Renal vein renin measurements in children with hypertension. Br Med J 1978, 2(6131):168-170.
73. Goonasekera CD, et al. The usefulness of renal vein renin studies in hypertensive children: a 25-year experience. Pediatr Nephrol 2002, 17(11):943-949.
74. White PC Disorders of aldosterone biosynthesis and action. N Engl J Med 1994, 331(4):250-258.
75. Whitworth JA Mechanisms of glucocorticoid-induced hypertension. Kidney Int 1987, 31(5):1213-1224.
76. Blumenfeld JD, et al. Diagnosis and treatment of primary hyperal-dosteronism. Ann Intern Med 1994, 121(11):877-885.
77. Walport MJ Complement. First of two parts. N Engl J Med 2001, 344(14):1058-1066.
78. Walport MJ Complement. Second of two parts, N. Engl J Med 2001, 344(15):1140-1144.
79. Thurman JM, Holers VM The central role of the alternative complement pathway in human disease. J Immunol 2006, 176(3):1305-1310.
80. Huber-Lang M, et al. Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med 2006, 12(6):682-687.
81. Hebert LA, Cosio FG, Neff JC Diagnostic significance of hypocomplementemia. Kidney Int 1991, 39(5):811-821.
82. Davies DJ, et al. Segmental necrotising glomerulonephritis with anti-neutrophil antibody: possible arbovirus aetiology?. Br Med J (Clin Res Ed) 1982, 285(6342):606.
83. Savige J, et al. International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA). Am J Clin Pathol 1999, 111(4):507-513.
84. Mandl LA, et al. Using antineutrophil cytoplasmic antibody testing to diagnose vasculitis: can test-ordering guidelines improve diagnostic accuracy?. Arch Intern Med 2002, 162(13):1509-1514.
85. Bosch X, Guilabert A, Font J Antineutrophil cytoplasmic antibodies. Lancet 2006, 368(9533):404-418.
86. Birck R, et al. Serial ANCA determinations for monitoring disease activity in patients with ANCA-associated vasculitis: systematic review. Am J Kidney Dis 2006, 47(1):15-23.
87. Saisoong S, Eiam-Ong S, Hanvivatvong O Correlations between antinucleosome antibodies and anti-double-stranded DNA antibodies, C3, C4, and clinical activity in lupus patients. Clin Exp Rheumatol 2006, 24(1):51-58.
88. Malleson PN, Sailer M, Mackinnon MJ Usefulness of antinuclear antibody testing to screen for rheumatic diseases. Arch Dis Child 1997, 77(4):299-304.
89. Haynes DC, et al. Autoantibody profiles in juvenile arthritis. J Rheumatol 1986, 13(2):358-363.
90. Hogg RJ, et al. Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation conference on proteinuria, albuminuria, risk, assessment, detection, and elimination (PARADE). Pediatrics 2005, 105(6):1242-1249.
91. Cabral DA, et al. Persistent antinuclear antibodies in children without identifiable inflammatory rheumatic or autoimmune disease. Pediatrics 1992, 89(3):441-444.
92. Tan EM, et al. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum 1997, 40(9):1601-1611.
93. Cervera R, et al. Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy. Ann Rheum Dis 2003, 62(5):431-434.
94. Harmoinen A, et al. Reference intervals for cystatin C in pre- and full-term infants and children. Pediatr Nephrol 2000, 15(1-2):105-108.
95. Matos V, et al. Urinary phosphate/creatinine, calcium/creatinine, and magnesium/creatinine ratios in a healthy pediatric population. J Pediatr 1997, 131(2):252-257.